Bupropion hydrochloride is a generic prescription drug used for depression and seasonal affective disorder. Bupropion comes as oral tablets. Bupropion, also called bupropion hydrochloride ...

For a second year in a row, Currax delivered greater than 50% year-over-year revenue growth for CONTRAVE®/MYSIMBA® in 2024. These outsized results were driven by increased patient demand, improved ...

Currax Pharmaceuticals LLC ("Currax"), a specialty Pharmaceutical company with over 25 products, including the number one branded oral weight loss medication CONTRAVE® (naltrexone HCl/bupropion ...

including the number one branded oral weight loss medication CONTRAVE ® (naltrexone HCl/bupropion HCl), today announces 2024 over-performance for revenue, demand and achievement of key ...

The campaign inspires individuals to seek help in taking control of their weight-loss efforts with CONTRAVE, an established ...

He had received bupropion hydrochloride extended release 150 mg orally daily for three days, followed by 150 mg orally twice daily. He was on day 20 of therapy and had not smoked during that time.

The model was used to compare outcomes for coverage versus no coverage of sustained-release bupropion hydrochloride as a component of a smoking- cessation benefit under four managed care plan ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

HCL Technologies Ltd (HCL Tech) Q3 results came more or less in line with expectations. Even as the IT major narrowed its revenue guidance, analysts said the hurdle rate for HCL Tech to now re ...

According to HDFC Securities, within the Tier 1 IT, HCL Technologies is expected to lead growth (and margin improvement), supported by software business seasonality in Q3. HCL Technologies may ...

According to the Centers for Disease Control and Prevention (CDC), 2 in 5 people in the United States have obesity. The obesity rate was 30.5% from 1999 to 2000. From 2017 to 2020, it increased to ...